Determinants of SARS-CoV-2 vaccinations in the 50+ population | Munich Center for the Economics of Aging - MEA
Home

Publications

Publication Series of the MPI for Social Policy

Determinants of SARS-CoV-2 vaccinations in the 50+ population

Content

With the arrival of effective COVID-19 vaccines, the main issue in the fight against the pandemic became how to quickly vaccinate as many people as possible to contain the pandemic and especially to protect those most at risk, e.g. the older population. After initial problems with vaccine supply have been overcome, the focus now is on a slowdown in vaccination uptake. The Survey on Health, Ageing and Retirement in Europe (SHARE) is in a unique position to provide insights into the reasons for vaccination hesitancy, as it very recently collected data on vaccination uptake and a number of influential factors from about 47,000 individuals in the high-risk 50+ age group across Europe and Israel. In this paper we will look at the interrelation of a willingness to get vaccinated with socio-demographic and health factors as well as living conditions and economic situations. The subjective and objective economic situtation as well as diagnosed physical illnesses and education show the strongest relation to vaccination hesitancy. The results in this paper provide a comprehensive picture of influential factors that might be helpful to further the success of the immunization campaigns in Europe.

Publication Details
Bergmann-2

Michael Bergmann

Hanneman_Tessa_MPISOC-Homepage

Tessa-Virginia Hannemann

Arne-Bethmann

Arne Bethmann

csm_201907_alexander-schumacher-400x500_8c35034f2b

Alexander Schumacher

2021
Max Planck Institute for Social Law and Social Policy, Munich Center for the Economics of Aging (MEA)
Munich
View